Giuseppe Valenti

569 total citations
17 papers, 288 citations indexed

About

Giuseppe Valenti is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Giuseppe Valenti has authored 17 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Immunology and Allergy. Recurrent topics in Giuseppe Valenti's work include Asthma and respiratory diseases (16 papers), Respiratory and Cough-Related Research (9 papers) and Allergic Rhinitis and Sensitization (6 papers). Giuseppe Valenti is often cited by papers focused on Asthma and respiratory diseases (16 papers), Respiratory and Cough-Related Research (9 papers) and Allergic Rhinitis and Sensitization (6 papers). Giuseppe Valenti collaborates with scholars based in Italy, Australia and Netherlands. Giuseppe Valenti's co-authors include Claudia Crimi, Corrado Pelaia, Nunzio Crimi, Santi Nolasco, Girolamo Pelaia, Raffaele Campisi, Giovanna Elisiana Carpagnano, Nicola Scichilone, Maria Filomena Caiaffa and Giulia Scioscia and has published in prestigious journals such as Frontiers in Immunology, Clinical & Experimental Allergy and Journal of Clinical Medicine.

In The Last Decade

Giuseppe Valenti

16 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppe Valenti Italy 11 246 188 100 48 48 17 288
Sofia Necander Sweden 6 193 0.8× 131 0.7× 150 1.5× 71 1.5× 61 1.3× 18 334
Warner Carr United States 8 91 0.4× 69 0.4× 36 0.4× 16 0.3× 37 0.8× 21 145
Clairelyne Dupin France 8 72 0.3× 103 0.5× 13 0.1× 38 0.8× 30 0.6× 32 181
Anat Shavit United Kingdom 4 84 0.3× 103 0.5× 14 0.1× 33 0.7× 45 0.9× 23 140
Sylvie Costo France 3 55 0.2× 124 0.7× 7 0.1× 27 0.6× 85 1.8× 6 154
Aaron Juche Germany 3 33 0.1× 132 0.7× 9 0.1× 8 0.2× 95 2.0× 8 148
Zohra Carton France 5 119 0.5× 234 1.2× 3 0.0× 24 0.5× 14 0.3× 10 265
Chris Ambrose United States 3 40 0.2× 30 0.2× 10 0.1× 60 1.3× 68 1.4× 13 138
Yasuhiko Noguchi Japan 7 45 0.2× 251 1.3× 12 0.1× 152 3.2× 2 0.0× 11 326
Matthew E. Herberg United States 7 97 0.4× 127 0.7× 8 0.1× 60 1.3× 1 0.0× 9 260

Countries citing papers authored by Giuseppe Valenti

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Valenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Valenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Valenti more than expected).

Fields of papers citing papers by Giuseppe Valenti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Valenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Valenti. The network helps show where Giuseppe Valenti may publish in the future.

Co-authorship network of co-authors of Giuseppe Valenti

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Valenti. A scholar is included among the top collaborators of Giuseppe Valenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Valenti. Giuseppe Valenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Carpagnano, Giovanna Elisiana, Andrea Portacci, Santi Nolasco, et al.. (2024). Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission. Frontiers in Immunology. 15. 1343362–1343362. 18 indexed citations
2.
Portacci, Andrea, Raffaele Campisi, Enrico Buonamico, et al.. (2023). Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis. ERJ Open Research. 9(5). 419–2023. 11 indexed citations
3.
Scioscia, Giulia, Pasquale Tondo, Santi Nolasco, et al.. (2023). Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience. Journal of Clinical Medicine. 12(13). 4362–4362. 4 indexed citations
4.
Nolasco, Santi, Andrea Portacci, Raffaele Campisi, et al.. (2023). Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study. Frontiers in Immunology. 14. 1204444–1204444. 24 indexed citations
5.
Rumi, G, Giorgio Walter Canonica, Juliet M. Foster, et al.. (2022). Digital Coaching Using Smart Inhaler Technology to Improve Asthma Management in Patients With Asthma in Italy: Community-Based Study. JMIR mhealth and uhealth. 10(11). e25879–e25879. 11 indexed citations
6.
Caminati, Marco, Gianna Camiciottoli, Ilaria Baiardini, et al.. (2022). Patients and doctors group meetings: an innovative way to explore severe asthma backstage. Multidisciplinary Respiratory Medicine. 17. 854–854.
7.
Pelaia, Corrado, Claudia Crimi, Santi Nolasco, et al.. (2021). Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy. Biomedicines. 9(12). 1822–1822. 20 indexed citations
8.
Pelaia, Corrado, Claudia Crimi, Nunzio Crimi, et al.. (2021). Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma. Expert Review of Respiratory Medicine. 16(2). 183–195. 6 indexed citations
9.
Nolasco, Santi, Claudia Crimi, Corrado Pelaia, et al.. (2021). Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study. The Journal of Allergy and Clinical Immunology In Practice. 9(12). 4371–4380.e4. 49 indexed citations
10.
Pelaia, Corrado, Claudia Crimi, Alida Benfante, et al.. (2021). Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression. Journal of Asthma and Allergy. Volume 14. 163–173. 41 indexed citations
11.
Valenti, Giuseppe, et al.. (2021). Exploring Machine Learning Techniques to Predict the Response to Omalizumab in Chronic Spontaneous Urticaria. Diagnostics. 11(11). 2150–2150. 4 indexed citations
12.
Pelaia, Corrado, Claudia Crimi, Girolamo Pelaia, et al.. (2020). Real‐life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype. Clinical & Experimental Allergy. 50(7). 780–788. 52 indexed citations
13.
Campisi, Raffaele, Claudia Crimi, Alberto Noto, et al.. (2020). Adherence to omalizumab: A multicenter "real-world" study. World Allergy Organization Journal. 13(2). 100103–100103. 21 indexed citations
14.
Crimi, Claudia, Raffaele Campisi, Santi Nolasco, et al.. (2020). Omalizumab versus mepolizumab in severe asthma: a propensity score matched efficiency retrospective cohort study. 2218–2218. 1 indexed citations
15.
Rumi, G, Fulvio Braido, Giorgio Walter Canonica, et al.. (2018). P171 Can the turbu+™ adherence programme contribute to improved adherence to asthma controller treatment in italy?. Data Archiving and Networked Services (DANS). A194.2–A195. 1 indexed citations
16.
Bongiorno, Maria Rita, Nunzio Crimi, Salvatore Corrao, et al.. (2016). Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice. Annals of Allergy Asthma & Immunology. 117(6). 703–707. 11 indexed citations
17.
Leonardi, Salvatore, M. Bruno, Paola Maria Cannaò, et al.. (2010). Olea sublingual allergoid immunotherapy administered with two different treatment regimens. Allergy and Asthma Proceedings. 31(2). 25–29. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sofia Necander Breakdown of academic impact, for papers by Warner Carr Breakdown of academic impact, for papers by Clairelyne Dupin Breakdown of academic impact, for papers by Anat Shavit Breakdown of academic impact, for papers by Sylvie Costo Breakdown of academic impact, for papers by Aaron Juche Breakdown of academic impact, for papers by Zohra Carton Breakdown of academic impact, for papers by Chris Ambrose Breakdown of academic impact, for papers by Yasuhiko Noguchi Breakdown of academic impact, for papers by Matthew E. Herberg
Rankless by CCL
2026